GB0505641D0 - Treatment of autoimmune and inflamatory diseases - Google Patents

Treatment of autoimmune and inflamatory diseases

Info

Publication number
GB0505641D0
GB0505641D0 GB0505641A GB0505641A GB0505641D0 GB 0505641 D0 GB0505641 D0 GB 0505641D0 GB 0505641 A GB0505641 A GB 0505641A GB 0505641 A GB0505641 A GB 0505641A GB 0505641 D0 GB0505641 D0 GB 0505641D0
Authority
GB
United Kingdom
Prior art keywords
autoimmune
treatment
inflamatory diseases
inflamatory
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0505641A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anamar Medical AB
Original Assignee
Anamar Medical AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anamar Medical AB filed Critical Anamar Medical AB
Priority to GB0505641A priority Critical patent/GB0505641D0/en
Publication of GB0505641D0 publication Critical patent/GB0505641D0/en
Priority to PCT/GB2006/000945 priority patent/WO2006097732A2/en
Ceased legal-status Critical Current

Links

GB0505641A 2005-03-18 2005-03-18 Treatment of autoimmune and inflamatory diseases Ceased GB0505641D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0505641A GB0505641D0 (en) 2005-03-18 2005-03-18 Treatment of autoimmune and inflamatory diseases
PCT/GB2006/000945 WO2006097732A2 (en) 2005-03-18 2006-03-16 Treatment of autoimmune and inflammatory diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0505641A GB0505641D0 (en) 2005-03-18 2005-03-18 Treatment of autoimmune and inflamatory diseases

Publications (1)

Publication Number Publication Date
GB0505641D0 true GB0505641D0 (en) 2005-04-27

Family

ID=34531511

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0505641A Ceased GB0505641D0 (en) 2005-03-18 2005-03-18 Treatment of autoimmune and inflamatory diseases

Country Status (2)

Country Link
GB (1) GB0505641D0 (en)
WO (1) WO2006097732A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090324585A1 (en) * 2008-06-12 2009-12-31 The Trustees of the Leland Standford Junior University Complement inhibitory agents as therapeutics in posttraumatic and degenerative arthritis
CN113087773B (en) * 2021-04-29 2022-02-18 安徽国肽生物科技有限公司 Yak bone peptide with blood sugar reducing and antioxidant functions and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004099784A2 (en) * 2003-05-06 2004-11-18 Anamar Medical Ab Method for determining a tissue degradation process by detection of fibromodulin neoepitopes

Also Published As

Publication number Publication date
WO2006097732A2 (en) 2006-09-21
WO2006097732A3 (en) 2006-12-21

Similar Documents

Publication Publication Date Title
EP1968607A4 (en) Treatment of cancer and other diseases
PL1951273T3 (en) Use of lactobacillus for treatment of autoimmune diseases
IL213843A0 (en) 4-aminotetracyclines and methods of use thereof
EP1945137A4 (en) Partially covered stent devices and methods of use
IL177849A0 (en) Methods and compositions for treatment of autoimmune diseases
EP1789047A4 (en) Treatment of diseases using nalmefene and its analgos
HK1118186A1 (en) Osteosynthetic implants and methods of use and manufacture
HUE041974T2 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
EP1931390A4 (en) Compositions and methods for treatment of autoimmune disease
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
ZA200802935B (en) Use of lactobacillus for treatment of autoimmune diseases
EP1906976A4 (en) Therapeutic polymers and methods of use
PL1960015T3 (en) Arrangement of medical treatment units and peripheral appliances
GB0421164D0 (en) Medical devices and methods of making medical devices
EP1858524A4 (en) Compositions and methods for treatment of autoimmune and related diseases
EP1733045A4 (en) Design and therapeutic use of adpase enhanced apyrases
ZA200709024B (en) Method of well treatment and construction
EP1773882A4 (en) Diagnosis and treatment of siglec-6 associated diseases
EP1881987A4 (en) Purine derivatives and their use for treatment of autoimmune diseases
EP1924286A4 (en) Phrophylactic and/or therapeutic method for treatment of autoimmune disease
GB0526394D0 (en) Treatment of inflammatory diseases
GB0505641D0 (en) Treatment of autoimmune and inflamatory diseases
GB0426196D0 (en) Methods of treatment
EP1725869A4 (en) Man2as as modifiers of the iger pathway and methods of use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)